Stay updated with breaking news from Demonstrate Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TN-301 Demonstrates Tolerability, Potential for Once Daily Dosing, Target Engagement and Selectivity for HDAC6 in Phase 1 Clinical Trial of Healthy Participants
Scores of anecdotal feedback over the years could lead many to conclude that cannabis is safe and effective for recreational and many medical uses. But, the lack of lab data halts any determination made by governments and departments such as the U.S. Food and Drug Administration (FDA). Proving the safety and efficacy of the plant remains difficult. Factors such as federal prohibition, cannabis use and the plant's makeup all play a part. The nascent space is doing its part to provide the federal government and consumers with assurances as best it can. Sources say the companies attempting t...
Parkinson's Disease), its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson's Disease (PD). Adaptive deep brain stimulation is an investigational feature of the Percept™ PC device that could be enabled if approved. The investigational feature used in this study allows for automated adjustment of brain stimulation to provide therapy to manage symptoms of Parkinson's disease based on a patient's clinical state. The randomized study will take place across 12 study sites at leading Movement Disorders research centers in the United S...